|
Volumn 6, Issue 3, 2007, Pages 352-355
|
A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZOIC ACID DERIVATIVE;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
CYCLOSPORIN;
DASATINIB;
DEFERASIROX;
EYE DROPS;
IRON CHELATING AGENT;
PROTEIN KINASE INHIBITOR;
PYRAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
THIAZOLE DERIVATIVE;
TRIAZOLE DERIVATIVE;
ANIMAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SKIN DISEASE;
SKIN TUMOR;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BENZOIC ACIDS;
BORONIC ACIDS;
CYCLOSPORINE;
HUMANS;
IRON CHELATING AGENTS;
OPHTHALMIC SOLUTIONS;
PROTEIN KINASE INHIBITORS;
PYRAZINES;
PYRIMIDINES;
RANDOMIZED CONTROLLED TRIALS;
SKIN DISEASES;
SKIN NEOPLASMS;
THIAZOLES;
TRIAZOLES;
|
EID: 34247197662
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (15)
|
References (36)
|